Lung Cancer Screening in Asia: An Expert Consensus Report
Issued Date
2023-01-01
Resource Type
ISSN
15560864
eISSN
15561380
Scopus ID
2-s2.0-85166561898
Pubmed ID
37390982
Journal Title
Journal of Thoracic Oncology
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Thoracic Oncology (2023)
Suggested Citation
Lam D.C.L., Liam C.K., Andarini S., Park S., Tan D.S.W., Singh N., Jang S.H., Vardhanabhuti V., Ramos A.B., Nakayama T., Nhung N.V., Ashizawa K., Chang Y.C., Tscheikuna J., Van C.C., Chan W.Y., Lai Y.H., Yang P.C. Lung Cancer Screening in Asia: An Expert Consensus Report. Journal of Thoracic Oncology (2023). doi:10.1016/j.jtho.2023.06.014 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/88317
Title
Lung Cancer Screening in Asia: An Expert Consensus Report
Author's Affiliation
VNU-University of Medicine and Pharmacy
Siriraj Hospital
Graduate School of Biomedical Sciences
The University of Hong Kong Li Ka Shing Faculty of Medicine
National Taiwan University Hospital
Lung Center of the Philippines
Universitas Indonesia
National Cancer Centre, Singapore
Universiti Malaya
Academia Sinica, Institute of Biomedical Sciences
Kuala Lumpur Hospital
National Taiwan University College of Medicine
Seoul National University Hospital
Hallym University
Postgraduate Institute of Medical Education & Research, Chandigarh
National Cancer Center Institute for Cancer Control
National Lung Hospital
Siriraj Hospital
Graduate School of Biomedical Sciences
The University of Hong Kong Li Ka Shing Faculty of Medicine
National Taiwan University Hospital
Lung Center of the Philippines
Universitas Indonesia
National Cancer Centre, Singapore
Universiti Malaya
Academia Sinica, Institute of Biomedical Sciences
Kuala Lumpur Hospital
National Taiwan University College of Medicine
Seoul National University Hospital
Hallym University
Postgraduate Institute of Medical Education & Research, Chandigarh
National Cancer Center Institute for Cancer Control
National Lung Hospital
Other Contributor(s)
Abstract
Introduction: The incidence and mortality of lung cancer are highest in Asia compared with Europe and USA, with the incidence and mortality rates being 34.4 and 28.1 per 100,000 respectively in East Asia. Diagnosing lung cancer at early stages makes the disease amenable to curative treatment and reduces mortality. In some areas in Asia, limited availability of robust diagnostic tools and treatment modalities, along with variations in specific health care investment and policies, make it necessary to have a more specific approach for screening, early detection, diagnosis, and treatment of patients with lung cancer in Asia compared with the West. Method: A group of 19 advisors across different specialties from 11 Asian countries, met on a virtual Steering Committee meeting, to discuss and recommend the most affordable and accessible lung cancer screening modalities and their implementation, for the Asian population. Results: Significant risk factors identified for lung cancer in smokers in Asia include age 50 to 75 years and smoking history of more than or equal to 20 pack-years. Family history is the most common risk factor for nonsmokers. Low-dose computed tomography screening is recommended once a year for patients with screening-detected abnormality and persistent exposure to risk factors. However, for high-risk heavy smokers and nonsmokers with risk factors, reassessment scans are recommended at an initial interval of 6 to 12 months with subsequent lengthening of reassessment intervals, and it should be stopped in patients more than 80 years of age or are unable or unwilling to undergo curative treatment. Conclusions: Asian countries face several challenges in implementing low-dose computed tomography screening, such as economic limitations, lack of efforts for early detection, and lack of specific government programs. Various strategies are suggested to overcome these challenges in Asia.